Sugarloaf Wealth Management’s Avanos Medical AVNS Stock Holding History

Sugarloaf Wealth Management’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$860	Hold	54	–	–	﹤0.01%	657
2024 Q3	$1.3K	Hold	54	–	–	﹤0.01%	629
2024 Q2	$1.08K	Hold	54	–	–	﹤0.01%	612
2024 Q1	$1.07K	Hold	54	–	–	﹤0.01%	622
2023 Q4	$1.21K	Hold	54	–	–	﹤0.01%	624
2023 Q3	$1.09K	Hold	54	–	–	﹤0.01%	622
2023 Q2	$1.38K	Hold	54	–	–	﹤0.01%	633
2023 Q1	$1.61K	Hold	54	–	–	﹤0.01%	627
2022 Q4	$1.46K	Hold	54	–	–	﹤0.01%	690
2022 Q3	$2K	Hold	54	–	–	﹤0.01%	698
2022 Q2	$1K	Hold	54	–	–	﹤0.01%	724
2022 Q1	$2K	Hold	54	–	–	﹤0.01%	634
2021 Q4	$2K	Hold	54	–	–	﹤0.01%	662
2021 Q3	$2K	Hold	54	–	–	﹤0.01%	678
2021 Q2	$2K	Hold	54	–	–	﹤0.01%	668
2021 Q1	$2	Hold	54	–	–	﹤0.01%	664
2020 Q4	$2K	Hold	54	–	–	﹤0.01%	626
2020 Q3	$2K	Hold	54	–	–	﹤0.01%	603
2020 Q2	$2K	Hold	54	–	–	﹤0.01%	596
2020 Q1	$1K	Hold	54	–	–	﹤0.01%	631
2019 Q4	$2K	Buy	+54	New	+$1.96K	﹤0.01%	624

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Sugarloaf Wealth Management's AVNS Position: Q4 2024 in Review

Sugarloaf Wealth Management held its Avanos Medical (AVNS) position steady in Q4 2024 at 54 shares worth $860. The position accounts for ﹤0.01% of the portfolio, ranked #657.

Sugarloaf Wealth Management first reported a position in AVNS in Q4 2019 and has held it in 21 quarters since. The position peaked at $2K in Q3 2022. 258 funds tracked by Wall St. Rank hold AVNS as of Q4 2024.

Sugarloaf Wealth Management held 54 shares of Avanos Medical worth $860 as of Q4 2024.
Sugarloaf Wealth Management left its Avanos Medical share count unchanged in Q4 2024.
Avanos Medical made up ﹤0.01% of Sugarloaf Wealth Management's portfolio in Q4 2024, its #657 holding.
Sugarloaf Wealth Management first reported a position in Avanos Medical in Q4 2019 and has held it in 21 quarters since.
Sugarloaf Wealth Management's Avanos Medical position peaked at $2K in Q3 2022.
258 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2024.

Based on Sugarloaf Wealth Management's 13F filing for Q4 2024, filed 10 Jan 2025.